|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Current assets: | |||||||||
| Cash | |||||||||
| Prepaid Insurance | |||||||||
| Prepaid expenses | |||||||||
| Total current assets | |||||||||
| Non-current assets | |||||||||
| Prepaid insurance | |||||||||
| Deferred offering costs associated with initial public offering | |||||||||
| Cash and marketable securities held in trust account | |||||||||
| Total assets | |||||||||
| Liabilities and stockholders' deficit | |||||||||
| Current liabilities: | |||||||||
| Accounts payable | |||||||||
| Accrued expenses | |||||||||
| Note payable-related party | |||||||||
| Total current liabilities | |||||||||
| Warrant liabilities | |||||||||
| Deferred underwriting fee payable | |||||||||
| Total liabilities | |||||||||
| Class A common stock subject to possible redemption 31,927,080 shares at redemption value at $10 per share | |||||||||
| Class A common stock subject to possible redemption 34,500,000 shares at redemption value at $10 per share | |||||||||
| Class A common stock subject to redemption | |||||||||
| Total class A common stock subject to possible redemption 34,500,000 shares at redemption value at $10 per share | |||||||||
| Stockholders' deficit: | |||||||||
| Common stock | |||||||||
| Class A common stock | |||||||||
| Class A common stock not subject to redemption | |||||||||
| Total class A common stock | |||||||||
| Class B common stock | |||||||||
| Total common stock | |||||||||
| Additional paid-in capital | |||||||||
| Accumulated deficit | |||||||||
| Total stockholders' deficit | |||||||||
| Total liabilities and stockholders' deficit |
Loading...
